Clients

Q Biomed Inc.

Company Snapshot: Q Biomed Inc.

QBIO
Last Change Volume High Low

Company Overview

Q BioMed Inc. is a biomedical acceleration and development company. We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need.

By partnering with exceptional entrepreneurs we aim to help to create market-leading products and companies in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.

Client News

  1. Mar 19 2019 Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University
  2. Mar 11 2019 Q BioMed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression from Washington University
  3. Mar 11 2019 Q BioMed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression from Washington University
  4. Feb 26 2019 Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper